109 related articles for article (PubMed ID: 11295221)
1. PEGylated polycyanoacrylate nanoparticles as tumor necrosis factor-alpha carriers.
Li YP; Pei YY; Zhou ZH; Zhang XY; Gu ZH; Ding J; Zhou JJ; Gao XJ
J Control Release; 2001 Apr; 71(3):287-96. PubMed ID: 11295221
[TBL] [Abstract][Full Text] [Related]
2. [Preparation and stability of recombinant human tumor necrosis factor-alpha-loaded stealth nanoparticles].
Fang C; Shi B; Pei YY
Yao Xue Xue Bao; 2004 Nov; 39(11):939-43. PubMed ID: 15696938
[TBL] [Abstract][Full Text] [Related]
3. PEGylated polycyanoacrylate nanoparticles as salvicine carriers: synthesis, preparation, and in vitro characterization.
Li YP; Zhou ZH; Pei YY; Zhang XY; Gu ZH; Yuan WF
Acta Pharmacol Sin; 2001 Jul; 22(7):645-50. PubMed ID: 11749831
[TBL] [Abstract][Full Text] [Related]
4. Stealth polycyanoacrylate nanoparticles as tumor necrosis factor-alpha carriers: pharmacokinetics and anti-tumor effects.
Li YP; Pei YY; Zhou ZH; Zhang XY; Gu ZH; Ding J; Zhou JJ; Gao XJ; Zhu JH
Biol Pharm Bull; 2001 Jun; 24(6):662-5. PubMed ID: 11411555
[TBL] [Abstract][Full Text] [Related]
5. Effect of MePEG molecular weight and particle size on in vitro release of tumor necrosis factor-alpha-loaded nanoparticles.
Fang C; Shi B; Pei YY
Acta Pharmacol Sin; 2005 Feb; 26(2):242-9. PubMed ID: 15663906
[TBL] [Abstract][Full Text] [Related]
6. In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size.
Fang C; Shi B; Pei YY; Hong MH; Wu J; Chen HZ
Eur J Pharm Sci; 2006 Jan; 27(1):27-36. PubMed ID: 16150582
[TBL] [Abstract][Full Text] [Related]
7. [Influence of particle size and MePEG molecular weight on in vitro macrophage uptake and in vivo long circulating of stealth nanoparticles in rats].
Fang C; Shi B; Hong MH; Pei YY; Chen HZ
Yao Xue Xue Bao; 2006 Apr; 41(4):305-12. PubMed ID: 16856473
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles bearing polyethyleneglycol-coupled transferrin as gene carriers: preparation and in vitro evaluation.
Li Y; Ogris M; Wagner E; Pelisek J; Rüffer M
Int J Pharm; 2003 Jun; 259(1-2):93-101. PubMed ID: 12787639
[TBL] [Abstract][Full Text] [Related]
9. Stealth PEG-PHDCA niosomes: effects of chain length of PEG and particle size on niosomes surface properties, in vitro drug release, phagocytic uptake, in vivo pharmacokinetics and antitumor activity.
Shi B; Fang C; Pei Y
J Pharm Sci; 2006 Sep; 95(9):1873-87. PubMed ID: 16795003
[TBL] [Abstract][Full Text] [Related]
10. PEGylated recombinant human tumor necrosis factor alpha: pharmacokinetics and anti-tumor effects.
Li YP; Pei YY; Zhou ZH; Zhang XY; Gu ZH; Ding J; Gao XJ; Zhu JH
Biol Pharm Bull; 2001 Jun; 24(6):666-70. PubMed ID: 11411556
[TBL] [Abstract][Full Text] [Related]
11. Pegylated nanoparticles from a novel methoxypolyethylene glycol cyanoacrylate-hexadecyl cyanoacrylate amphiphilic copolymer.
Peracchia MT; Vauthier C; Desmaële D; Gulik A; Dedieu JC; Demoy M; d'Angelo J; Couvreur P
Pharm Res; 1998 Apr; 15(4):550-6. PubMed ID: 9587950
[TBL] [Abstract][Full Text] [Related]
12. PEGylated recombinant human tumor necrosis factor alpha: preparation and anti-tumor potency.
Li YP; Pei YY; Ding J; Shen ZM; Zhang XY; Gu ZH; Zhou JJ
Acta Pharmacol Sin; 2001 Jun; 22(6):549-55. PubMed ID: 11747763
[TBL] [Abstract][Full Text] [Related]
13. PEGylated polycyanoacrylate nanoparticles as vector for drug delivery in prion diseases.
Calvo P; Gouritin B; Brigger I; Lasmezas C; Deslys J; Williams A; Andreux JP; Dormont D; Couvreur P
J Neurosci Methods; 2001 Oct; 111(2):151-5. PubMed ID: 11595281
[TBL] [Abstract][Full Text] [Related]
14. Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery.
Calvo P; Gouritin B; Chacun H; Desmaële D; D'Angelo J; Noel JP; Georgin D; Fattal E; Andreux JP; Couvreur P
Pharm Res; 2001 Aug; 18(8):1157-66. PubMed ID: 11587488
[TBL] [Abstract][Full Text] [Related]
15. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats.
Li Y; Pei Y; Zhang X; Gu Z; Zhou Z; Yuan W; Zhou J; Zhu J; Gao X
J Control Release; 2001 Apr; 71(2):203-11. PubMed ID: 11274752
[TBL] [Abstract][Full Text] [Related]
16. Body distribution and in situ evading of phagocytic uptake by macrophages of long-circulating poly (ethylene glycol) cyanoacrylate-co-n-hexadecyl cyanoacrylate nanoparticles.
Huang M; Wu W; Qian J; Wan DJ; Wei XL; Zhu JH
Acta Pharmacol Sin; 2005 Dec; 26(12):1512-8. PubMed ID: 16297352
[TBL] [Abstract][Full Text] [Related]
17. Stealth PEG-PHDCA niosomes: effects of chain length of PEG on niosomes in vitro complement consumption and phagocytic uptake.
Shi B; Fang C; You MX; Hong MH; Pei YY
Yao Xue Xue Bao; 2005 Nov; 40(11):976-81. PubMed ID: 16499079
[TBL] [Abstract][Full Text] [Related]
18. Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting.
Peracchia MT; Fattal E; Desmaële D; Besnard M; Noël JP; Gomis JM; Appel M; d'Angelo J; Couvreur P
J Control Release; 1999 Jun; 60(1):121-8. PubMed ID: 10370176
[TBL] [Abstract][Full Text] [Related]
19. Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA.
Perez C; Sanchez A; Putnam D; Ting D; Langer R; Alonso MJ
J Control Release; 2001 Jul; 75(1-2):211-24. PubMed ID: 11451511
[TBL] [Abstract][Full Text] [Related]
20. Translocation of poly(ethylene glycol-co-hexadecyl)cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins in receptor-mediated endocytosis.
Kim HR; Andrieux K; Gil S; Taverna M; Chacun H; Desmaële D; Taran F; Georgin D; Couvreur P
Biomacromolecules; 2007 Mar; 8(3):793-9. PubMed ID: 17309294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
